Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelon: a randomized controlled study

INTERVENTION: control group:Treatment of oral Mecobalamin tablets;Treatment group:Electroacupuncture Treatment; CONDITION: Cancer;Peripheral nerve diseases PRIMARY OUTCOME: Peripheral neurotoxicity was assessed according to NCI CTCAE version 5.0;PNQ;EORTC QLQ‐CIPN20; SECONDARY OUTCOME: EORTC QLQ‐C30; INCLUSION CRITERIA: ? According to the diagnostic criteria of CIPN, recent use of utidelon chemotherapy resulted in grade I and above peripheral neuropathy; ? Age 18‐70 years old; ? Have the ability of daily living, Karnofsky function score > 70, and can cooperate independently to complete all treatments; ? No severe diseases such as gravity center, liver, brain and kidney, and no serious mental diseases; ? Voluntarily participate and sign informed consent.